Pyrazoloheteroaryls:: Novel p38α MAP kinase inhibiting scaffolds with oral activity

被引：79

作者：

Revesz, L ^{[1
]}

Blum, E ^{[1
]}

Di Padova, FE ^{[1
]}

Buhl, T ^{[1
]}

Feifel, R ^{[1
]}

Gram, H ^{[1
]}

Hiestand, P ^{[1
]}

Manning, U ^{[1
]}

Neumann, U ^{[1
]}

Rucklin, G ^{[1
]}

机构：

[1] Novartis Inst Biomed Res, Global Discovery Chem, CH-4002 Basel, Switzerland

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2006年 / 16卷 / 02期

关键词：

p38; inhibition; MAP kinase inhibition; rheumatoid arthriitis; antiarthritic; anti-inflammatory; collagen-induced arthritis; adjuvant-induced arthritis;

D O I：

10.1016/j.bmcl.2005.10.015

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A test library with three novel p38 alpha inhibitory scaffolds and a narrow set of substituents was prepared. Appropriate combination of substituent and scaffold generated potent p38 alpha inhibitors, for example, pyrazolo[3,4-b]pyridine 9, pyrazolo[3,4-d]pyrimidine 18a and pyrazolo[3,4-b]pyrazine 23b with potent in vivo activity upon oral administration in animal models of rheumatoid arthritis. (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：262 / 266

页数：5

共 50 条

[31] Quantitative structure activity relationship study of p38α MAP kinase inhibitors
Pourbasheer, Eslam
Ahmadpour, Sajjad
Zare-Dorabei, Rohollah
Nekoei, Mehdi
ARABIAN JOURNAL OF CHEMISTRY, 2017, 10 (01) : 33 - 40
[32] Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
Christopher Pargellis
Liang Tong
Laurie Churchill
Pier F. Cirillo
Thomas Gilmore
Anne G. Graham
Peter M. Grob
Eugene R. Hickey
Neil Moss
Susan Pav
John Regan
Nature Structural Biology, 2002, 9 : 268 - 272
[33] p38 MAP kinase pathway regulates [GSH]
Xiu, M
Huang, CY
Paulson, KE
FASEB JOURNAL, 2000, 14 (08): : A1454 - A1454
[34] Osteoblastic cell differentiation and p38 MAP kinase
Dziak, R
Dahman, M
Lampasso, J
BONE, 2005, 36 : S287 - S287
[35] Cytokines, p38 MAP Kinase and the Pathophysiology of Depression
Andrew H Miller
Charles L Raison
Neuropsychopharmacology, 2006, 31 : 2089 - 2090
[36] Activation and signaling of the p38 MAP kinase pathway
Tyler ZARUBIN
CellResearch, 2005, (01) : 11 - 18
[37] Benzothiazole based inhibitors of p38α MAP kinase
Liu, Chunjian
Lin, James
Pitt, Sidney
Zhang, Rosemary F.
Sack, John S.
Kiefer, Susan E.
Kish, Kevin
Doweyko, Arthur M.
Zhang, Hongjian
Marathe, Punit H.
Trzaskos, James
Mckinnon, Murray
Dodd, John H.
Barrish, Joel C.
Schieven, Gary L.
Leftheris, Katerina
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (06) : 1874 - 1879
[38] Imidazopyrimidines, potent inhibitors of p38 MAP kinase
Rupert, KC
Henry, JR
Dodd, JH
Wadsworth, SA
Cavender, DE
Olini, GC
Fahmy, B
Siekierka, JJ
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) : 347 - 350
[39] Synthesis of a naphthyridone p38 MAP kinase inhibitor
Chung, John Y. L.
Cvetovich, Raymond J.
McLaughlin, Mark
Amato, Joseph
Tsay, Fuh-Rong
Jensen, Mark
Weissman, Steve
Zewge, Daniel
JOURNAL OF ORGANIC CHEMISTRY, 2006, 71 (22): : 8602 - 8609
[40] P38 MAP kinase inhibitors for the treatment of arthritis
Barlocco, D
Langston, S
DRUG DISCOVERY TODAY, 2001, 6 (15) : 808 - 809

← 1 2 3 4 5 →